FDA Clears Avastin for Breast Cancer
February 23, 2008 By MATTHEW PERRONE, AP Business Writer(AP) -- A Genentech drug received federal approval on Friday to treat breast cancer, a surprise decision that could represent a shift in standards for assessing the effectiveness of cancer medicines.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Drugs to treat anemia in cancer patients linked to thromboembolism
20 hours ago |
2.5 / 5 (2) |
1
Experts: Placebo power behind many natural cures
Nov 10, 2009 |
5 / 5 (1) |
1
Expanding drug treatment: Is US ready to step up?
Nov 08, 2009 |
not rated yet |
1
Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
Nov 02, 2009 |
not rated yet |
0
Study finds stroke risk from anemia drug Aranesp
Oct 31, 2009 |
4 / 5 (1) |
0



I think the NBCC needs a new president. "...progression-free survival..." is pretty d**n important when you have cancer.